0 items USD 0.00Search
- Did you mean
- psoriasis arthrex
Your search for "Psoriatic arthritis" gave back 672 results.
The “Arthritic Therapeutic Industry Forecast” looks at past sales and reviews total world Arthritic Therapeutic sales in 2022, providing a...
Catalog:
LPI
February 2023
Price: USD 3,660.00
An autoimmune disease is a condition arising from an abnormal immune response to a functioning body part. There are at least 80 types of autoimmune...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Highlights The global Arthritic Therapeutic market was valued at US$ 28340 million in 2022 and is anticipated to reach US$ 35210 million by 2029,...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Abatacept (marketed as Orencia) is a drug used to treat autoimmune diseases like rheumatoid arthritis, by interfering with the immune activity of T...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) that explicitly targets enzymes responsible for inflammation and pain namely...
Catalog:
LPI
February 2023
Price: USD 3,660.00
TNF Alpha Inhibitor are a group of medicines that suppress the body's natural response to tumor necrosis factor (TNF), a protein produced by...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Musculoskeletal Disorders Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Etoricoxib Intermediate market size was valued at US$ million in 2023. With growing demand in downstream market, the Etoricoxib...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Infliximab and Biosimilar market size was valued at US$ million in 2023. With growing demand in downstream market, the Infliximab and...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Arthritic Therapeutic market was valued at US$ 27240 million in 2023 and is anticipated to reach US$ 35210 million by 2030, witnessing a...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Tumor necrosis factor inhibitor drug helps to stop physiologic response to tumor necrosis factor. The “Tumor Necrosis Factor Inhibitor Drug Industry...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Arthritic Therapeutic market size was valued at US$ 26650 million in 2023. With growing demand in downstream market, the Arthritic...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Market Analysis and Insights: Global Arthritic Therapeutic Market The global Arthritic Therapeutic market is projected to grow from US$ 28340 million...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Tumor necrosis factor inhibitor drug helps to stop physiologic response to tumor necrosis factor. According to our Publisher latest study, the global...
Catalog:
GIR
February 2023
Price: USD 3,480.00
